Last reviewed · How we verify
NCT04397081
Atopic Diseases & Human Papilloma Virus
trial testing HPV test results in Human Papilloma Virus in 239 participants. Completed in 30 March 2020.
29 February 2020
Quick facts
| Lead sponsor | Adana Numune Training and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 239 |
| Start date | 1 August 2019 |
| Primary completion | 29 February 2020 |
| Estimated completion | 30 March 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- HPV test results
Conditions studied
- Human Papilloma Virus — all drugs for Human Papilloma Virus →
- Atopic Asthma — all drugs for Atopic Asthma →
- Atopic Disorders — all drugs for Atopic Disorders →
Sponsor
Adana Numune Training and Research Hospital
Who can join
Adults 30 to 65, female only, with Human Papilloma Virus or Atopic Asthma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cervical cancer is an important health problem in women. Human papillomavirus (HPV) is considered the primary etiological agent of cervical cancer worldwide. Cervical cancer screening methods are proved one of the few screening methods that are thought to decrease invasive cancer incidence and mortality. In our country, HPV screening is carried out free of charge by public health to women between the ages of 30-65 aim is to compare HPV screening results between women diagnosed with atopic disease and healthy women without a history of atopy.If HPV is detected more frequently in patients with atopy, it may be recommended to follow more closely in vaccination and screening programs. Therefore, our study was designed to evaluate whether HPV positivity is common in atopic women.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04397081
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Human Papilloma Virus
Currently open trials in the same condition.
- NCT07336134 — PopSci CHW4CervixHealth · NA · recruiting
- NCT06414057 — HPV Equity Study: Exploring Cervical Cancer Control in Scotland for Women With Experience of Priority Risks · recruiting
- NCT06747390 — Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery · Phase 1 · recruiting
- NCT06598176 — Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples · NA · recruiting
- NCT05996783 — Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial · NA · active not recruiting
Other Adana Numune Training and Research Hospital trials
Trials by the same sponsor.
- NCT04064801 — Red Cell Distribution Width as a Predictor of Mortality in Acute Methanol Poisoning · completed
- NCT03124524 — Treatment Choice in Primary Dysmenorrhea · Phase 4 · completed
- NCT03127293 — Hyperemesis Gravidarum and Osteoporosis · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04397081 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Adana Numune Training and Research Hospital
- Last refreshed: 26 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04397081.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing